Difficulties remain in the NP size/shape dispersity, relevant dose delivered to the tumor and the low number of studies exploring AMPs-MNPs formulations in cancer; together, these factors are the major challenge for the success of new DDSs based on metal scaffolds [145,203]. This evidence concerns the gene ADSL and cancer.